CDC Grand Rounds: Improving Medication Adherence for Chronic Disease Management — Innovations and Opportunities

Neiman, Andrea; Ruppar, Todd; Ho, Michael; Garber, Larry; Weidle, Paul J.; Hong, Yuling; George, Mary G.; Thorpe, Phoebe

doi:10.15585/mmwr.mm6645a2

Cited by 111 publications

(117 citation statements)

References 18 publications

Supporting

Mentioning

113

Contrasting

Unclassified

Order By: Relevance

“…Medications are an important aspect of the treatment of chronic disease; 5.8 billion prescriptions were filled in the United States in 2018 (6). Medication therapy management (MTM) improves the safe and effective use of medications, including resolving drug therapy problems, promoting adherence, and increasing continuity of care, as well as improving measures of patient and provider satisfaction (7)(8)(9)(10)(11)(12)(13). Ensuring appropriate medication use can improve CVD clinical outcomes, reduce mortality rates, and decrease health care costs (14).…”

Section: Introductionmentioning

confidence: 99%

The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta

et al. 2020

View full text Add to dashboard Cite

What is known on this topic? The Mississippi Delta has high rates of chronic disease and is known for its poor health outcomes and health disparities. Medication therapy management (MTM) improves the safe and effective use of medications, and ensuring appropriate medication use can improve clinical outcomes related to cardiovascular disease (CVD). What does this research add to the literature? Pharmacists met face-to-face in federally qualified health centers with patients who had a diagnosis of diabetes, hypertension, and/or dyslipidemia to provide MTM. Patients experienced mean reductions in systolic and diastolic blood pressure, low-density lipoprotein cholesterol, triglycerides, total cholesterol, and hemoglobin A 1c. What are the implications for public health practice? MTM is an effective way to improve CVD outcomes in residents of regions like the Mississippi Delta that have high rates of poverty, health disparities, and poor health outcomes.

show abstract

Section: Introductionmentioning

confidence: 99%

The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta

et al. 2020

View full text Add to dashboard Cite

show abstract

“…National policy changes, such as Medicaid expansion, could have had an impact on the UDS clinical QI percent scores for FQHCs in Illinois (10). One study found that at federally funded community health centers, Medicaid expansion was associated with improved clinical quality for 4 of the 8 measures examined: asthma treatment, Papanicolaou testing, body mass index assessment, and controlled blood pressure (18). Additionally, our study did not account for patient-specific demographics and other factors like medication adherence, encounter frequency, and health literacy that affect chronic disease management (19)(20)(21).…”

Section: Discussionmentioning

confidence: 95%

Evidence-Based Interventions for High Blood Pressure and Glycemic Control Among Illinois Health Systems

et al. 2020

View full text Add to dashboard Cite

What is already known on this topic? Analyses of health systems interventions on chronic disease management and the variation of clinical quality improvement percent scores is limited. What is added by this report? This study underscores the variability that can occur within and across federally qualified health centers in Illinois around the number and type of policies, systems, and processes implemented. What are the implications for public health practice? When considering the tactics of implementing evidence-based chronic disease management, health systems should consider the difference between the number and types of policies, systems, and processes that address hypertension and diabetes control.

show abstract

“…Gambar 1. Alasan yang dilaporkan karena ketidakpatuhan terhadap rejimen pengobatan yang direkomendasikan (Neiman et al, 2017).…”

Section: Hasil Dan Pembahasanunclassified

Faktor-Faktor yang Mempengaruhi Ketaatan Minum Obat pada Penyakit Kronik

Farisi

2020

JIUBJ

View full text Add to dashboard Cite

Adherence is a key factor related to the effectiveness of all pharmacological therapies. Non-compliance with treatment is a significant barrier to achieving positive health outcomes especially for patients suffering from chronic diseases. Improving medication adherence is a public health priority and can reduce the economic and health burden. The purpose of this study is to assess treatment compliance with several common chronic diseases. There are many challenges in understanding the reasons for non-compliance. The main component in the management of patients with chronic health problems is the assessment of their adherence to therapeutic regimens. Low levels of patient adherence to therapeutic effectiveness have been associated with increased adverse health risks, increased spending on health care through hospitals and hospital care, lower quality of life, and higher rates of death. In this study treatment adherence to chronic diseases found suboptimal and is associated with socio-demographic characteristics of patients. Patient-adjusted interventions are needed to achieve adequate adherence to therapeutic drug regimens. The good outcome of chronic illness depends greatly on the level of patient compliance with treatment. Many studies have shown that some degree of non-compliance occurs universally, in rich and poor countries, and is even seen in life-threatening diseases.

show abstract

CDC Grand Rounds: Improving Medication Adherence for Chronic Disease Management — Innovations and Opportunities

Cited by 111 publications

References 18 publications

The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta

The Mississippi Delta Health Collaborative Medication Therapy Management Model: Public Health and Pharmacy Working Together to Improve Population Health in the Mississippi Delta

Evidence-Based Interventions for High Blood Pressure and Glycemic Control Among Illinois Health Systems

Faktor-Faktor yang Mempengaruhi Ketaatan Minum Obat pada Penyakit Kronik

Contact Info

Product

Resources

About